Is Henry Schein (HSIC) a risky stock?
As of July 21, 2026, Clavix grades Henry Schein (HSIC) B for risk, a composite score of 72 out of 100 on an A+ to F scale, which puts HSIC in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind HSIC's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how HSIC scores on each, as of July 21, 2026.
What's moving HSIC's risk right now
Company-specific signals Clavix flags behind HSIC's current grade, drawn from recent news and filings as of July 21, 2026.
Despite modest stock price appreciation that mirrors the broader market, Henry Schein's underlying business fundamentals show slowing organic growth and limited near-term revenue…
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying at…
The partnership expands Henry Schein's value proposition to dental practitioners by integrating workforce/staffing solutions, potentially strengthening customer retention and comp…
What a B grade means
On the Clavix A+ to F scale, HSIC's composite of 72 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell HSIC or any security. Grades are risk indicators, not predictions of return. Data may be delayed.